Auxilium Pharmaceuticals Inc. (NASD:AUXL) was a big mover last session, as the company saw its shares rise by over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up nearly 22% in the past one-month time frame.

The company has seen no estimate revision over the past 30 days and the Zacks Consensus Estimate remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Auxilium Pharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Investors interested in the medical sector may consider stocks like Endocyte, Inc. (NASD:ECYT), Grifols, S.A. (NASD:GRFS) and Lannett Company, Inc. (NYSE:LCI). All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


AUXILIUM PHARMACEUTICALS INC (AUXL): Free Stock Analysis Report

ENDOCYTE INC (ECYT): Free Stock Analysis Report

GRIFOLS SA ADS (GRFS): Free Stock Analysis Report

LANNETT COMP (LCI): Free Stock Analysis Report


Zacks Investment Research